October 27, 2026
A program that determines prescription drug costs across the country is being hashed out in the courts. Here are three cases to watch that could have lasting effects on the program's future.
October 31, 2022
Eli Lilly & Co. ran into tough questions about the Seventh Circuit's power to review a closely watched case over the scope of a multibillion-dollar drug discount program, after a judge asked Monday if a violation letter was something the court could look at now.
May 26, 2022
Eli Lilly & Co. says an Indiana federal judge wrongly found that a nationwide drug discount program requires pharmaceutical companies to provide those discounted drugs to certain types of pharmacies, saying the outcome of an appeal at the Seventh Circuit would carry "profound consequences."